PepGen (PEPG) Other Non Operating Income (2021 - 2026)
PepGen (PEPG) reported Other Non Operating Income of -$56000.0 for Q1 2026, down 1766.67% on a YoY basis from $3360.0 in Q1 2025, and down 103.64% sequentially from $1.5 million in Q4 2025.
PepGen (PEPG) Other Non Operating Income (2021 - 2026) Analysis & Trends
PepGen (PEPG) has 6 years of Other Non Operating Income data on file, last reported at -$56000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income fell 1766.67% year-over-year to -$56000.0; the trailing twelve-month figure through Mar 2026 stood at $1.5 million (up 3248.94% YoY), and the FY2025 full-year result was $1.5 million, up 153400.0% from the prior year.
- Other Non Operating Income fell to -$56000.0 in Q1 2026, from $1.5 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $1.5 million in Q4 2025 to a low of -$88000.0 in Q3 2023.
- A 5-year average of $82294.1 and a median of -$3000.0 in 2025 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income plunged 2300.0% in 2023 and surged 5819.23% in 2025, its largest moves.
- Tracing PEPG's Other Non Operating Income over 5 years: stood at -$28000.0 in 2022, then soared by 253.57% to $43000.0 in 2023, then sank by 39.53% to $26000.0 in 2024, then surged by 5819.23% to $1.5 million in 2025, then sank by 103.64% to -$56000.0 in 2026.
- Business Quant data shows PEPG's Other Non Operating Income at -$56000.0 in Q1 2026, $1.5 million in Q4 2025, and -$6000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | PepGen | 145.09 Mn | 145.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -56,000.00 |
| Dec 31, 2025 | 1.54 Mn |
| Sep 30, 2025 | -6,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Mar 31, 2025 | -3,000.00 |
| Dec 31, 2024 | 26,000.00 |
| Sep 30, 2024 | -39,000.00 |
| Jun 30, 2024 | -31,000.00 |
| Mar 31, 2024 | 43,000.00 |
| Dec 31, 2023 | 43,000.00 |
| Sep 30, 2023 | -88,000.00 |
| Jun 30, 2023 | -62,000.00 |
| Mar 31, 2023 | -80,000.00 |
| Dec 31, 2022 | -28,000.00 |
| Sep 30, 2022 | 4,000.00 |
| Jun 30, 2022 | 76,000.00 |
| Mar 31, 2022 | 58,000.00 |
| Dec 31, 2021 | 67,000.00 |
| Sep 30, 2021 | -34,000.00 |
| Jun 30, 2021 | -197,000.00 |